このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
COMPASS Pathways 将来の成長
Future 基準チェック /06
COMPASS Pathways利益と収益がそれぞれ年間37.2%と71.3%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に-97.2% 39.2%なると予測されています。
主要情報
37.2%
収益成長率
39.2%
EPS成長率
| Biotechs 収益成長 | 24.3% |
| 収益成長率 | 71.3% |
| 将来の株主資本利益率 | -97.2% |
| アナリストカバレッジ | Good |
| 最終更新日 | 10 May 2024 |
今後の成長に関する最新情報
Recent updates
Compass Pathways: Buy It For Its Promising Psychedelic Mental Health Therapies
Jul 08Psychedelics Closer To Commercialization; Compass Far And Away The Leader
May 23COMPASS Pathways: Will MDMA-Assisted Therapy Pave The Way Or Slam The Door Shut?
Apr 25Compass Pathways: Psilocybin Developer A Potentially Intriguing, Contrarian Play
Feb 08Companies Like COMPASS Pathways (NASDAQ:CMPS) Are In A Position To Invest In Growth
Dec 06
Booker again pushes for easier access to psychedelics for terminally ill patients
Oct 19Here's Why We're Not Too Worried About COMPASS Pathways' (NASDAQ:CMPS) Cash Burn Situation
Aug 13COMPASS Pathways And The Trillion Dollar Opportunity
Aug 11COMPASS Pathways ADS Q2 2022 Earnings Preview
Aug 03COMPASS Pathways names new CEO
Jul 19Compass Pathways: Shares Look Cheap But Proving Psilocybin Case Won't Be Easy
Jun 30We're Hopeful That COMPASS Pathways (NASDAQ:CMPS) Will Use Its Cash Wisely
Apr 28Checking In On Compass Pathways
Mar 02We Think COMPASS Pathways (NASDAQ:CMPS) Can Afford To Drive Business Growth
Dec 29Compass Pathways: Psychedelics For Mental Health
Nov 23Compass Faces Tricky Road To Approval For Its Psychedelic Depressive Therapy
Sep 17COMPASS Pathways (NASDAQ:CMPS) Is In A Good Position To Deliver On Growth Plans
Sep 15Compass Pathways: Huge Growth Potential, But I'm Cautious
Jun 04COMPASS Pathways (NASDAQ:CMPS) Is In A Good Position To Deliver On Growth Plans
May 25COMPASS Pathways raises $144M capital via equity offering
Apr 30COMPASS Pathways launches public offering
Apr 27We're Not Very Worried About COMPASS Pathways' (NASDAQ:CMPS) Cash Burn Rate
Feb 08Psilocybin Will Change Mental Health, Compass Pathways Could Be At The Forefront
Jan 01Compass Pathways: Risky And Overvalued
Dec 18What Type Of Shareholders Make Up COMPASS Pathways plc's (NASDAQ:CMPS) Share Registry?
Dec 18COMPASS Pathways: Risky But Can Pay Back Generously
Dec 14Compass Pathways: An Overvalued Psychedelic Company With A Single Mediocre Drug
Nov 23COMPASS Pathways ADS reports Q3 results
Nov 12業績と収益の成長予測
| 日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
|---|---|---|---|---|---|
| 12/31/2026 | 33 | -189 | -163 | -148 | 5 |
| 12/31/2025 | N/A | -164 | -130 | -122 | 5 |
| 12/31/2024 | N/A | -145 | -109 | -105 | 7 |
| 3/31/2024 | N/A | -129 | -91 | -90 | N/A |
| 12/31/2023 | N/A | -118 | -97 | -97 | N/A |
| 9/30/2023 | N/A | -117 | -115 | -115 | N/A |
| 6/30/2023 | N/A | -102 | -117 | -117 | N/A |
| 3/31/2023 | N/A | -95 | -111 | -110 | N/A |
| 12/31/2022 | N/A | -92 | -106 | -105 | N/A |
| 9/30/2022 | N/A | -86 | -83 | -83 | N/A |
| 6/30/2022 | N/A | -84 | -78 | -77 | N/A |
| 3/31/2022 | N/A | -80 | -77 | -77 | N/A |
| 12/31/2021 | N/A | -72 | -68 | -68 | N/A |
| 9/30/2021 | N/A | -65 | -62 | -62 | N/A |
| 6/30/2021 | N/A | -66 | -62 | -62 | N/A |
| 3/31/2021 | N/A | -64 | -51 | -51 | N/A |
| 12/31/2020 | N/A | -60 | -42 | -41 | N/A |
| 9/30/2020 | N/A | -49 | -31 | -31 | N/A |
| 6/30/2020 | N/A | -38 | -22 | -22 | N/A |
| 3/31/2020 | N/A | -25 | -19 | -19 | N/A |
| 12/31/2019 | N/A | -20 | -18 | -18 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: CMPS今後 3 年間、利益が出ない状態が続くと予測されています。
収益対市場: CMPS今後 3 年間、利益が出ない状態が続くと予測されています。
高成長収益: CMPS今後 3 年間、利益が出ない状態が続くと予測されています。
収益対市場: CMPS来年は収益がないと予測されています。
高い収益成長: CMPS来年は収益がないと予測されています。
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: CMPS 3 年以内に赤字になると予測されています。